World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: CTRI
Last refreshed on: 24 November 2021
Main ID:  CTRI/2016/11/007465
Date of registration: 10-11-2016
Prospective Registration: No
Primary sponsor: CBCI Society for Medical Education
Public title: A Research project to reduce the risk of heart attack and strokes at work place.
Scientific title: Policy and peer mentor intervention programs on cardiovascular disease at small to medium sized worksites in 3 South Asian countries - PROGRESS
Date of first enrolment: 15-02-2016
Target sample size: 3000
Recruitment status: Closed to Recruitment of Participants
URL:  http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=10592
Study type:  Interventional
Study design:  Other
Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label
 
Phase:  N/A
Countries of recruitment
Bangladesh India Sri Lanka
Contacts
Name: Dr Deepak Kamath MD   
Address:  Division of Clinical Research and Training, St.Johns Research Institute, Koramangala, Bangalore 560 034 Bangalore, KARNATAKA India
Telephone: 9945519522
Email: kamath.deepak@sjri.res.in
Affiliation:  Division of Clinical Research and Training
Name: Dr Deepak Kamath MD   
Address:  Division of Clinical Research and Training, St.Johns Research Institute, Koramangala, Bangalore 560 034 Bangalore, KARNATAKA India
Telephone: 9945519522
Email: kamath.deepak@sjri.res.in
Affiliation:  Division of Clinical Research and Training
Key inclusion & exclusion criteria
Inclusion criteria: (All criteria must be met to be eligible)



1.Employees(Men & Women)above the age of 35 years.

2.Permanent employees with at least 6 months for retirement.

3.Willing to provide Informed Consent.

Exclusion criteria: (Subject ineligible if even one criterion is met)



1.Pregnant or intent to get pregnant in one year.

2.Inability to attend follow up visits.

3.Any active malignancy or Known malignancy on treatment.

4.Will be relocated during the study period.

5.Unwilling or unable to comply with study procedures.


Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Intervention(s)
Intervention1: Educational Intervention.: Employees above the age of 35 years will be risk stratified into moderate or high risk of developing cardiovascular disease using a simple non-lab based risk scoring system. They will be invited to participate in the pilot intervention study. This is a single arm before-after study. Subject education will focus on lifestyle modification and adherence to medication(If applicable). Importantly the peer mentor will try to identify barriers to adopting a healthy lifestyle(tobacco, physical activity, diet, alcohol and stress) and adherence to Cardio Vascular Disease prevention medications (which are already prescribed by their treating physician). The peer mentor will be trained to detect and refer (to treating physician or company panel doctor) participants who have a high blood pressure. Peer mentors will be trained to interpret blood glucose and lipids, recognize abnormal values, provide lifestyle counseling and refer to treating physician when appropriate.
Control Intervention1: Not Applicable: Not Applicable
Primary Outcome(s)
1)Change in knowledge attitudes & practices related to Cardio Vascular (CV) risk factors.

2)Identification of barriers and facilitators for an optimal Cardio Vascular Disease (CVD) environment.

3) Estimate the CardioVascular (CV) risk burden at 6 worksites in 3 countries using a non-lab based risk scoring system.

4) Feasibility and acceptability of the interventions to reduce cardiovascular risk.Timepoint: 3 Months
Secondary Outcome(s)
1) Identify & Train Peer Mentors (PMs) to deliver an educational intervention.

2) Change in Blood Pressure among identified hypertensives (The study is not powered to detect this change at 3 month.)Timepoint: 3 Months
Secondary ID(s)
NIL
Source(s) of Monetary Support
Medical Research council(UK), 2nd Floor David Philips Buiding, Polaris House, North Star Avenue Swindon wiltshire SN21F1, United Kindgom. Grant ref. no.MR/M019624/1
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 05/12/2014
Contact:
Institutional Ethics Committee, St.Johns National Academy of Health Sciences,Bangalore.
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history